Paula N. Friedman

6.6k total citations · 2 hit papers
62 papers, 4.3k citations indexed

About

Paula N. Friedman is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Paula N. Friedman has authored 62 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 19 papers in Molecular Biology and 8 papers in Hepatology. Recurrent topics in Paula N. Friedman's work include HER2/EGFR in Cancer Research (9 papers), Cancer-related Molecular Pathways (9 papers) and Hepatitis B Virus Studies (7 papers). Paula N. Friedman is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer-related Molecular Pathways (9 papers) and Hepatitis B Virus Studies (7 papers). Paula N. Friedman collaborates with scholars based in United States, Japan and United Kingdom. Paula N. Friedman's co-authors include Carol Prives, Jill Bargonetti, Bert Vogelstein, Scott E. Kern, Arthur M. Bruskin, Kenneth W. Kinzler, Hua Zhu, George E. Farmer, Ron Prywes and D R Marshak and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Paula N. Friedman

58 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of p53 as a Sequence-Specific DNA-Binding Protein

1991 935 citations Scott E. Kern, Paula N. Friedman et al. profile →
Wild-type p53 activates transcription in vitro

1992 517 citations Jill Bargonetti, Paula N. Friedman et al. profile →

Peers

Countries citing papers authored by Paula N. Friedman

Since Specialization

Citations

This map shows the geographic impact of Paula N. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula N. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula N. Friedman more than expected).

Fields of papers citing papers by Paula N. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula N. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula N. Friedman. The network helps show where Paula N. Friedman may publish in the future.

Co-authorship network of co-authors of Paula N. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Paula N. Friedman. A scholar is included among the top collaborators of Paula N. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paula N. Friedman. Paula N. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation of Genomic and Transcriptomic Risk Factors of Clopidogrel Response in African Americans 2025 ·Clinical Pharmacology & Therapeutics ·Guang Yang, Cristina Alarcón, (unknown), Norman H. Lee, Paula N. Friedman, Edith A. Nutescu, Matthew Tuck, Travis J. O’Brien, Li Gong, Teri E. Klein, Kyong‐Mi Chang, Philip S. Tsao, David O. Meltzer, Julie A. Lynch, (unknown), Sony Tuteja, Minoli A. Perera	0
2	Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance) 2024 ·The Pharmacogenomics Journal ·Jai N. Patel, Chen Jiang, Kouros Owzar, Daniel L. Hertz, Janey Wang, Flora Mulkey, William Kevin Kelly, Susan Halabi, Yoichi Furukawa, (unknown), Susan G. Dorsey, Paula N. Friedman, Eric J. Small, Michael A. Carducci, Michael J. Kelley, Yusuke Nakamura, Michiaki Kubo, Mark J. Ratain, Michael J. Morris, Howard L. McLeod	0
3	Genomewide Meta‐Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent‐Induced Sensory Peripheral Neuropathy 2020 ·Clinical Pharmacology & Therapeutics ·(unknown), Chenling Xiong, (unknown), Taisei Mushiroda, J Chen, Flora Mulkey, Dongbing Lai, Bryan P. Schneider, Sara R. Rashkin, John S. Witte, Paula N. Friedman, Mark J. Ratain, Howard L. McLeod, Hope S. Rugo, Lawrence N. Shulman, Michiaki Kubo, Kouros Owzar, Deanna L. Kroetz	25
4	Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance) 2016 ·Journal of Clinical Oncology ·Donna Niedzwiecki, Wendy L. Frankel, Alan P. Venook, Xing Ye, Paula N. Friedman, Richard M. Goldberg, Robert J. Mayer, Thomas A. Colacchio, Jude M. Mulligan, Timothy S. Davison, Eamonn O’Brien, Peter Kerr, Patrick G. Johnston, Richard D. Kennedy, D. Paul Harkin, Richard L. Schilsky, Monica M. Bertagnolli, Robert S. Warren, Federico Innocenti	35
5	Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance) 2015 ·JNCI Journal of the National Cancer Institute ·Lynn G. Dressler, Allison M. Deal, Kouros Owzar, Dorothy Watson, (unknown), Paula N. Friedman, Mark J. Ratain, Howard L. McLeod	8
6	Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581 2013 ·Journal of Clinical Oncology ·Alan P. Venook, Donna Niedzwiecki, Margarita Lopatin, Xing Ye, Mark Lee, Paula N. Friedman, Wendy L. Frankel, Kim M. Clark-Langone, Carl Millward, Steven Shak, Richard M. Goldberg, Najjia N. Mahmoud, Robert S. Warren, Richard L. Schilsky, Monica M. Bertagnolli	117
7	Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance) 2013 ·Clinical Cancer Research ·Andrew B. Nixon, Herbert Pang, Mark D. Starr, Paula N. Friedman, Monica M. Bertagnolli, Hedy L. Kindler, Richard M. Goldberg, Alan P. Venook, Herbert I. Hurwitz	82
8	A genome-wide association study (GWAS) of docetaxel-induced peripheral neuropathy in CALGB 90401 (Alliance). 2013 ·Journal of Clinical Oncology ·Daniel L. Hertz, Kouros Owzar, Susan Halabi, William Kevin Kelly, Hitoshi Zembutsu, Chen Jiang, Jai N. Patel, Dorothy Watson, Ivo Shterev, Deanna L. Kroetz, Paula N. Friedman, John F. Mahoney, Michael A. Carducci, Michael J. Kelley, Eric J. Small, Phillip G. Febbo, Yusuke Nakamura, Michiaki Kubo, Mark J. Ratain, Howard L. McLeod	1
9	A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101 2012 ·Clinical Cancer Research ·R. Michael Baldwin, Kouros Owzar, Hitoshi Zembutsu, Aparna Chhibber, Michiaki Kubo, Chen Jiang, Dorothy Watson, (unknown), Joel Mefford, Howard L. McLeod, Paula N. Friedman, Clifford A. Hudis, Eric P. Winer, Eric Jorgenson, John S. Witte, Lawrence N. Shulman, Yusuke Nakamura, Mark J. Ratain, Deanna L. Kroetz	160
10	Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer 2007 ·Clinical Cancer Research ·Lyndsay N. Harris, Fanglei You, Stuart J. Schnitt, Agnes Witkiewicz, Xin Lü, Dennis C. Sgroi, Paula D. Ryan, Steven E. Come, Harold J. Burstein, (unknown), (unknown), Paula N. Friedman, Rebecca Gelman, J. Dirk Iglehart, Eric P. Winer	190
11	Evaluation of expression based markers for the detection of breast cancer cells 2005 ·Breast Cancer Research and Treatment ·Nicholas M. Brown, Timothy T. Stenzel, Paula N. Friedman, Jerry G. Henslee, Gudrun Hüper, Jeffrey R. Marks	24
12	Hepatitis G virus in clotting factor concentrates 2003 ·Haemophilia ·(unknown), (unknown), Paula N. Friedman, (unknown), Cindy Leissinger	3
13	Identification and Immunohistochemical Characterization of a Mucin-Like Glycoprotein Expressed in Early Stage Breast Carcinoma 2002 ·Tumor Biology ·Tracey Colpitts, P Billing, (unknown), (unknown), Steve Hodges, Lisa Roberts, John M. Russell, Paula N. Friedman, (unknown)	21
14	GB Virus Type C Viremia and Envelope Antibodies among Population Subsets in The Netherlands 1999 ·Vox Sanguinis ·(unknown), Greet J. Boland, C.L. van der Poel, (unknown), (unknown), J.J. van der Reijden, Paula N. Friedman, (unknown), E. F. van Leeuwen, Jan van Hattum	10
15	Multicenter trial on mother-to-infant transmission of GBV-C virus 1998 ·Journal of Medical Virology ·Alessandro Zanetti, Elisabetta Tanzi, Luisa Romanò, Nicola Principi, Giovanna Zuin, E. Minola, (unknown), (unknown), Antonio Marini, Daniela Ghisotti, Paula N. Friedman, Jeffrey C. Hunt, T G Laffler, (unknown)	54
16	Detection of GB virus C by the RT-PCR LCx® system 1998 ·Journal of Virological Methods ·(unknown), (unknown), Paula N. Friedman, (unknown), (unknown), (unknown), Cheryl Jennings, (unknown), (unknown), T G Laffler, Nancy J. Lewis, (unknown), (unknown), (unknown), (unknown)	12
17	Phosphorylation and active ATP hydrolysis are not required for SV40 T antigen hexamer formation. 1993 ·Journal of Biological Chemistry ·Inga Reynisdóttir, Heather E. Lorimer, Paula N. Friedman, (unknown), Carol Prives	17
18	Murine p53 inhibits the function but not the formation of SV40 T antigen hexamers and stimulates T antigen RNA helicase activity 1992 ·Chromosoma ·Paula N. Friedman, (unknown), Karen Meerovitch, Nahum Sonenberg, Carol Prives	1
19	Functional Consequences of the Interactions of the p53 Tumor Suppressor Protein and SV40 Large Tumor Antigen 1991 ·Cold Spring Harbor Symposia on Quantitative Biology ·Carol Prives, Jill Bargonetti, Paula N. Friedman, James J. Manfredi, (unknown)	10
20	Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication 1991 ·Cell ·Jill Bargonetti, Paula N. Friedman, Scott E. Kern, Bert Vogelstein, Carol Prives	327

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact